Zevra Therapeutics, Inc. ZVRA
10.26 USD +0.16 (+1.58%)
At closeNov 3, 2026, 4:00 PM EST
10.68 +0.42 +4.09%
After hours · Nov 3, 4:00 PM ET
10.04 Day range 10.42
8.01 52-week range 15.04
- YTD
- +14.51%
- 1 year
- +0.49%
Analyst view
Price target (mean) 20.00 +94.9% upside
Now 10.26
- Target (low)
- 14.00
- Target (mean)
- 20.00
- Target (high)
- 25.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
- Strong buy4
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.40286 | -0.54 – -0.29 | -0.40 | -0.7% | 8.78M | -33.6% | 7 |
| Next quarter | 0.0875 | -0.30 – 1.19 | -0.40 | +121.9% | 31.06M | +806.8% | 4 |
| Current year | -1.94 | -2.14 – -1.54 | -1.30 | -49.0% | 20.36M | -25.8% | 7 |
| Next year | -0.31714 | -1.33 – 0.85 | -1.94 | +83.6% | 98.43M | +383.3% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 11, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Oct 7, 2024 | Guggenheim | Initiated | — | Buy |
| Oct 1, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Sep 30, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 24, 2024 | JMP Securities | Initiated | — | Market Outperform |
| Sep 24, 2024 | Maxim Group | Maintained | Buy | Buy |
| Sep 24, 2024 | Roth MKM | Maintained | Buy | Buy |
| Sep 20, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 18, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 14, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Aug 5, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Aug 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 1, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Mar 12, 2024 | William Blair | Initiated | — | Outperform |
| Mar 5, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 28, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 6, 2023 | Roth MKM | Reiterated | Buy | Buy |
| Sep 1, 2023 | Canaccord Genuity | Reiterated | Buy | Buy |
| Aug 15, 2023 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 17, 2023 | Maxim Group | Initiated | — | Buy |